Human prostate tumors express CX3CR1, which facilitates their adhesion to bone marrow CX3CL1-expressing endothelial cells as well as osteoblasts, and triggers PI3K/AKT pathway activation [233]. This evidence concerns the gene CX3CL1 and prostate neoplasm.